MNWCX | NLSIX | MNWCX / NLSIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 13 years | - |
Gain YTD | 6.050 | 6.246 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 36M | 6.97B | 1% |
Annual Yield % from dividends | 0.00 | 0.63 | - |
Returns for 1 year | 6.52 | 8.56 | 76% |
Returns for 3 years | 6.91 | 4.06 | 170% |
Returns for 5 years | 10.56 | 27.49 | 38% |
Returns for 10 years | 20.17 | 44.45 | 45% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MAAYX | 10.08 | N/A | N/A |
Morgan Stanley US Focus Real Estate A | |||
JMCCX | 61.33 | -0.46 | -0.74% |
JPMorgan Mid Cap Equity C | |||
GSZPX | 27.99 | -0.50 | -1.76% |
Goldman Sachs Small Cap Gr Insghts P | |||
NBMIX | 51.59 | -1.08 | -2.05% |
Neuberger Berman Small Cap Growth Inv | |||
ETIHX | 33.97 | -1.69 | -4.74% |
Eventide Healthcare & Life Sciences I |